Sectoral Asset Management as of June 30, 2018
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 67 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Amicus Therapeutics (FOLD) | 6.5 | $58M | 3.7M | 15.62 | |
Aerie Pharmaceuticals | 4.7 | $42M | 616k | 67.55 | |
Apellis Pharmaceuticals (APLS) | 4.3 | $38M | 1.7M | 22.00 | |
La Jolla Pharmaceuticl Com Par | 4.3 | $38M | 1.3M | 29.17 | |
Portola Pharmaceuticals | 3.4 | $30M | 795k | 37.77 | |
Alnylam Pharmaceuticals (ALNY) | 3.3 | $30M | 304k | 98.49 | |
EXACT Sciences Corporation (EXAS) | 3.2 | $29M | 479k | 59.79 | |
Teladoc (TDOC) | 3.1 | $28M | 473k | 58.05 | |
Sarepta Therapeutics (SRPT) | 3.0 | $27M | 206k | 132.18 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 3.0 | $27M | 1.1M | 23.85 | |
Array BioPharma | 2.9 | $26M | 1.6M | 16.78 | |
BioMarin Pharmaceutical (BMRN) | 2.7 | $25M | 261k | 94.20 | |
Alexion Pharmaceuticals | 2.5 | $22M | 180k | 124.15 | |
K2m Group Holdings | 2.4 | $21M | 951k | 22.50 | |
Gilead Sciences (GILD) | 2.1 | $19M | 264k | 70.84 | |
Abiomed | 2.1 | $19M | 45k | 409.05 | |
Pfizer (PFE) | 2.0 | $18M | 490k | 36.28 | |
Molina Healthcare (MOH) | 2.0 | $18M | 179k | 97.94 | |
Johnson & Johnson (JNJ) | 1.9 | $17M | 140k | 121.34 | |
Novartis (NVS) | 1.9 | $17M | 225k | 75.54 | |
Clovis Oncology | 1.9 | $17M | 369k | 45.47 | |
Immunomedics | 1.8 | $17M | 696k | 23.67 | |
Alder Biopharmaceuticals | 1.8 | $16M | 1.0M | 15.80 | |
Unum Therapeutics Ord | 1.7 | $16M | 1.1M | 14.35 | |
UnitedHealth (UNH) | 1.7 | $15M | 62k | 245.34 | |
Acceleron Pharma | 1.7 | $15M | 307k | 48.52 | |
Adamas Pharmaceuticals | 1.6 | $14M | 536k | 25.83 | |
Pra Health Sciences | 1.6 | $14M | 149k | 93.36 | |
Medtronic (MDT) | 1.4 | $13M | 148k | 85.61 | |
Irhythm Technologies (IRTC) | 1.3 | $12M | 145k | 81.13 | |
Bristol Myers Squibb (BMY) | 1.2 | $11M | 194k | 55.34 | |
Madrigal Pharmaceuticals (MDGL) | 1.2 | $11M | 38k | 279.69 | |
Eli Lilly & Co. (LLY) | 1.2 | $11M | 123k | 85.33 | |
Global Blood Therapeutics In | 1.2 | $10M | 231k | 45.20 | |
Evolent Health (EVH) | 1.1 | $9.9M | 469k | 21.05 | |
Esperion Therapeutics (ESPR) | 0.9 | $8.2M | 211k | 39.19 | |
Insulet Corporation (PODD) | 0.9 | $8.1M | 95k | 85.70 | |
Obseva Sa | 0.9 | $8.1M | 538k | 15.14 | |
Wright Medical Group Nv | 0.9 | $8.0M | 308k | 25.96 | |
Hill-Rom Holdings | 0.9 | $7.9M | 91k | 87.34 | |
CIGNA Corporation | 0.9 | $7.8M | 46k | 169.95 | |
Nevro (NVRO) | 0.8 | $6.7M | 84k | 79.85 | |
Viewray (VRAYQ) | 0.8 | $6.7M | 966k | 6.92 | |
Boston Scientific Corporation (BSX) | 0.7 | $6.2M | 190k | 32.70 | |
Albireo Pharma | 0.7 | $6.1M | 173k | 35.50 | |
Edwards Lifesciences (EW) | 0.7 | $5.9M | 41k | 145.57 | |
Sage Therapeutics (SAGE) | 0.7 | $5.8M | 37k | 156.52 | |
Abbott Laboratories (ABT) | 0.6 | $5.7M | 94k | 60.99 | |
Incyte Corporation (INCY) | 0.6 | $5.3M | 79k | 66.99 | |
Evelo Biosciences | 0.6 | $5.2M | 438k | 11.80 | |
Rocket Pharmaceuticals (RCKT) | 0.5 | $4.7M | 237k | 19.63 | |
Ptc Therapeutics I (PTCT) | 0.5 | $4.6M | 136k | 33.73 | |
Meiragtx Holdings (MGTX) | 0.5 | $4.3M | 375k | 11.46 | |
Masimo Corporation (MASI) | 0.5 | $4.1M | 42k | 97.65 | |
Vocera Communications | 0.4 | $3.9M | 131k | 29.89 | |
Intec Pharma | 0.4 | $3.9M | 890k | 4.40 | |
Savara (SVRA) | 0.4 | $3.8M | 332k | 11.32 | |
Nektar Therapeutics (NKTR) | 0.4 | $3.6M | 74k | 48.84 | |
Homology Medicines | 0.3 | $2.9M | 144k | 20.40 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $2.4M | 34k | 71.03 | |
Celgene Corporation | 0.2 | $1.8M | 23k | 79.40 | |
Spring Bk Pharmaceuticals In | 0.2 | $1.6M | 132k | 11.85 | |
Clementia | 0.2 | $1.5M | 112k | 13.16 | |
Zai Lab (ZLAB) | 0.1 | $1.1M | 49k | 23.26 | |
Shire | 0.1 | $760k | 4.5k | 168.89 | |
Dr. Reddy's Laboratories (RDY) | 0.1 | $695k | 22k | 32.18 | |
Sierra Oncology | 0.1 | $597k | 202k | 2.96 |